Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Similar articles for PubMed (Select 24066405)

1.

Metabolic syndrome: differences between psychiatric and internal medicine patients.

Margari F, Lozupone M, Pisani R, Pastore A, Todarello O, Zagaria G, Minerva F, Palasciano G, Palmieri V.

Int J Psychiatry Med. 2013;45(3):203-26.

PMID:
24066405
3.

Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.

Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M.

Food Nutr Bull. 2009 Jun;30(2):161-70.

PMID:
19689095
4.

Decreased high-density lipoprotein cholesterol and insulin resistance were the most common criteria in 12- to 19-year-old adolescents.

Budak N, Oztürk A, Mazicioglu M, Yazici C, Bayram F, Kurtoglu S.

Eur J Nutr. 2010 Jun;49(4):219-25. doi: 10.1007/s00394-009-0066-2. Epub 2009 Oct 30.

PMID:
19876664
5.

Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.

Elmslie JL, Porter RJ, Joyce PR, Hunt PJ, Shand BI, Scott RS.

Aust N Z J Psychiatry. 2009 Jan;43(1):53-60. doi: 10.1080/00048670802534341.

PMID:
19085528
6.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
7.

[Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].

Roa Barrios M, Arata-Bellabarba G, Valeri L, Velázquez-Maldonado E.

Endocrinol Nutr. 2009 Feb;56(2):59-65. doi: 10.1016/S1575-0922(09)70553-4. Epub 2009 May 1. Spanish.

PMID:
19627713
8.

The contribution of abdominal obesity and dyslipidemia to metabolic syndrome in psychiatric patients.

Kim SH, Kim K, Kwak MH, Kim HJ, Kim HS, Han KH.

Korean J Intern Med. 2010 Jun;25(2):168-73. doi: 10.3904/kjim.2010.25.2.168. Epub 2010 Jun 1.

10.

[Metabolic syndrome in overweight and obese schoolchildren in Beijing].

Wan NJ, Mi J, Wang TY, Duan JL, Li M, Gong CX, Du JB, Zhao XY, Cheng H, Hou DQ, Wang L.

Zhonghua Er Ke Za Zhi. 2007 Jun;45(6):417-21. Chinese.

PMID:
17880785
11.

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study.

Filippatos TD, Kiortsis DN, Liberopoulos EN, Georgoula M, Mikhailidis DP, Elisaf MS.

Curr Med Res Opin. 2005 Dec;21(12):1997-2006.

PMID:
16368051
12.

Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance.

Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, March CE, Balbín E, Dulbecco CA, Aizpurúa M, Marillet AG, Reaven GM.

Diab Vasc Dis Res. 2013 Jul;10(4):346-52. doi: 10.1177/1479164113479809. Epub 2013 Apr 26.

13.

Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.

Shand BI, Scott RS, Lewis JG, Elder PA, Frampton CM.

Int J Obes (Lond). 2009 Nov;33(11):1274-9. doi: 10.1038/ijo.2009.169. Epub 2009 Sep 1.

PMID:
19721448
14.

Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.

Hummel J, Westphal S, Weber-Hamann B, Gilles M, Lederbogen F, Angermeier T, Luley C, Deuschle M, Kopf D.

J Clin Psychiatry. 2011 Jul;72(7):885-91. doi: 10.4088/JCP.09m05853blu. Epub 2011 Jan 25.

PMID:
21294998
16.

Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity.

Caceres M, Teran CG, Rodriguez S, Medina M.

BMC Pediatr. 2008 Aug 12;8:31. doi: 10.1186/1471-2431-8-31.

17.

Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls.

Kangas P, Tikkakoski AJ, Tahvanainen AM, Leskinen MH, Viitala JM, Kähönen M, Kööbi T, Niemelä OJ, Mustonen JT, Pörsti IH.

Metabolism. 2013 Aug;62(8):1114-22. doi: 10.1016/j.metabol.2013.02.009. Epub 2013 Apr 1.

PMID:
23557592
18.

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

Correll CU, Frederickson AM, Kane JM, Manu P.

Schizophr Res. 2007 Jan;89(1-3):91-100. Epub 2006 Oct 27.

19.

Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.

Kopf D, Westphal S, Luley CW, Ritter S, Gilles M, Weber-Hamann B, Lederbogen F, Lehnert H, Henn FA, Heuser I, Deuschle M.

J Clin Psychopharmacol. 2004 Oct;24(5):527-31.

PMID:
15349009
20.

The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype.

Basu R, Brar JS, Chengappa KN, John V, Parepally H, Gershon S, Schlicht P, Kupfer DJ.

Bipolar Disord. 2004 Aug;6(4):314-8.

PMID:
15225149
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk